Clinical Trials Browser

OTHER × Lymphoma, Follicular × loncastuximab tesirine × Clear all

NCT04998669 2026-02-10

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular

NCT05453396 2025-10-16

Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies

Phase 2 Recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07197307 2025-09-29

CLEAR

Phase 2 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse